Navidea Biopharmaceutical... (NAVB)
0.00
-0.00 (-100.00%)
At close: Feb 27, 2025, 3:00 PM
0.00
11.11%
Pre-market: Sep 03, 2024, 09:30 AM EDT
Corporate Segment Revenue
History
Quarter | Value | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 0 | -7.52K | -100.00% |
Sep 30, 2022 | 7.52K | -42.83K | -85.07% |
Dec 31, 2021 | 50.35K | -138.58K | -73.35% |
Dec 31, 2020 | 188.93K | 75.43K | +66.45% |
Sep 30, 2020 | 113.5K | 104.58K | +1172.44% |
Jun 30, 2020 | 8.92K | -65.22K | -87.97% |
Mar 31, 2020 | 74.14K | -20.27K | -21.47% |
Mar 31, 2019 | 94.41K | 88.9K | +1614.95% |
Dec 31, 2018 | 5.5K | -309.64K | -98.25% |
Dec 31, 2017 | 315.14K | 104.66K | +49.73% |
Sep 30, 2017 | 210.48K | -307.9K | -59.40% |
Jun 30, 2017 | 518.38K | -52.99K | -9.27% |
Mar 31, 2017 | 571.36K | -9.71M | -94.44% |
Sep 30, 2016 | 10.28M | 3.83M | +59.32% |
Jun 30, 2016 | 6.45M | 791.91K | +13.99% |
Mar 31, 2016 | 5.66M | -2.58M | -31.31% |
Dec 31, 2015 | 8.24M | 3.24M | +64.67% |
Sep 30, 2015 | 5.01M | 5.01M | n/a |
Jun 30, 2015 | 0 | n/a | n/a |
Mar 31, 2015 | 0 | n/a | n/a |